Option chain shows key data for Valhi's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Valhi.

Valhi (NYSE:VHI) Stock, Option Chain

Valhi

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.

Movers

News

Intraday Update

Markets

Trading Ideas

ARQT

ASTS

BILI

BWLP

CAVA

LIND

LUMN

Nuveen Arizona Dividend Advantage Municipal Funds 3

POWL

ROKU

WDAY

CAVA Group Posts Strong Q2 Results, Joins Bilibili, Workday And Other Big Stocks Moving Higher On Friday

Long Ideas

Penny Stocks

Small Cap

Pre-Market Outlook

AMRS

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Top 5 Materials Stocks That May Explode In May

AAMC

ACMR

ACOR

AERI

AMTD

AMTX

ASTR

ATCO

ATIF

ATNX

BBAI

BBBY

Brighthouse Financial, Inc. - Common Stock

BLUE

BNSO

BYND

CERE

CGTX

CLMT

CLNE

CNEY

CPOP

CVCO

CVNA

DKNG

DOCS

DRRX

EEIQ

EVFM

FEDU

FNKO

FOLD

FOXF

FUBO

GDOT

GHRS

GNLN

GTHX

HCAT

HIHO

HLBZ

HRTG

HSCS

HSDT

HSTO

HYRE

HYZN

ILAG

INTZ

IONM

IRBT

IXHL

KSPN

LOPE

LTRPA

LYFT

MOBQ

MRKR

MRTX

NEWR

NLOK

NNBR

OPEN

ORIC

PCTY

PEGY

PGNY

PROF

PTON

QNRX

RDBX

Lordstown Motors Corp. - Class A Common Stock

RIDE

SELB

SIEN

SPCE

SRRK

SRTS

STAF

STSA

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday

Valhi Inc

VITALHUB CORP COM NO PAR by VITALHUB CORP

Vitalhub Corp

Earnings

ACXP

ADAP

AEMD

AFCG

AFYA

AGRO

AIRJ

ALUR

ALVO

ARCO

ATEX

AYTU

BCDA

BETR

BFRI

BITF

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BNGO

BOXL

BRFS

BWEN

CAAS

CAPR

CREX

CRNT

CSAN

CSCO

CSLR

CSTE

CYBR

DADA

DGII

DMAC

DOLE

DTCK

ECOR

EDBL

ENLT

EZPW

FORA

FPAY

FULC

GILT

GLAD

GOEV

GRYP

HIVE

HROW

IBTA

ICAD

ICCC

INLX

INVZ

JAGX

JJSF

KBDC

KLIC

KMDA

KRMD

KULR

LMFA

LOAR

LQDA

LUCD

LVLU

MCRB

MPTI

MRSN

NTWK

NXGL

OMER

OPRX

OTRK

OWLT

OXBR

PAVM

PCYO

Earnings Scheduled For November 13, 2024

<p>Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) is preparing to release its quarterly earnings on Thursday, 2024-11-07. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Valhi to report an <strong>earnings per share</strong> (EPS) of $0.60.</p>
<p>Valhi bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company beat EPS by $0.41, leading to a 12.36% increase in the share price the following trading session.</p>
<p>Here's a look at Valhi's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.60</td>
<td>0.29</td>
<td></td>
<td></td>
<td>0.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.01</td>
<td>0.70</td>
<td>0.27</td>
<td>0.14</td>
<td>-0.21</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.000000000000001%</td>
<td>12.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Performance of Valhi Shares</h3>
<p>Shares of Valhi were trading at $31.47 as of November 11. Over the last 52-week period, shares are up 120.93%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Valhi</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Valhi.</p>
<p>With 1 analyst ratings, Valhi has a consensus rating of Underperform. The average one-year price target is $20.0, indicating a potential 36.45% downside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Ecovyst, Rayonier Adv Materials and Ginkgo Bioworks Holdings, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Ecovyst is maintaining an Buy status according to analysts, with an average 1-year price target of $10.5, indicating a potential 66.63% downside.</li>
<li>The consensus outlook from analysts is an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, indicating a potential 65.05% downside.</li>
<li>As per analysts' assessments, Ginkgo Bioworks Holdings is favoring an Buy trajectory, with an average 1-year price target of $8.5, suggesting a potential 72.99% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for Ecovyst, Rayonier Adv Materials and Ginkgo Bioworks Holdings are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valhi</td>
<td>Underperform</td>
<td>10.37%</td>
<td>$121.30M</td>
<td>2.10%</td>
</tr>
<tr>
<td>Ecovyst</td>
<td>Buy</td>
<td>3.37%</td>
<td>$54.70M</td>
<td>1.97%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>8.80%</td>
<td>$43.57M</td>
<td>-4.38%</td>
</tr>
<tr>
<td>Ginkgo Bioworks Holdings</td>
<td>Buy</td>
<td>-30.24%</td>
<td>$42.48M</td>
<td>-23.88%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Valhi ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. Valhi is at the bottom for Return on Equity.</p>
<h3>Unveiling the Story Behind Valhi</h3>
<p>Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.</p>
<h3>Unraveling the Financial Story of Valhi</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Valhi displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>10.37%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>3.56%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Valhi's ROE excels beyond industry benchmarks, reaching <strong>2.1%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.78%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.54</strong>, Valhi adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/VHI/earnings"><strong>To track all earnings releases for Valhi visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For Valhi

<p>Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported quarterly earnings of $2.01 per share.  The company reported $533.600 million in sales this quarter. This is a 13.80 percent increase over sales of $468.900 million the same period last year.</p>


Valhi Q3 2024 GAAP EPS $2.01, Sales $533.600M Up From $468.900M YoY

WIIM

Valhi shares are trading higher. Barclays raised its price target on the stock from $11 to $20.

<p>Barclays  analyst Michael Leithead   maintains Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) with a Underweight and raises the price target from $11 to $20.</p>


Price Target

Analyst Ratings

Barclays Maintains Underweight on Valhi, Raises Price Target to $20

Comments

Valhi

Valhi (VHI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga